1. Home
  2. TSLX vs RCKT Comparison

TSLX vs RCKT Comparison

Compare TSLX & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

SELL

Current Price

$17.19

Market Cap

1.8B

Sector

Finance

ML Signal

SELL

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

SELL

Current Price

$2.12

Market Cap

277.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TSLX
RCKT
Founded
2010
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
277.7M
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
TSLX
RCKT
Price
$17.19
$2.12
Analyst Decision
Buy
Buy
Analyst Count
11
14
Target Price
★ $19.52
$8.82
AVG Volume (30 Days)
471.5K
★ 1.6M
Earning Date
11-03-2026
11-12-2026
Dividend Yield
★ 10.15%
N/A
EPS Growth
N/A
★ 26.37
EPS
★ 0.51
0.23
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.15
$1,494.26
P/E Ratio
$34.22
★ $9.43
Revenue Growth
N/A
N/A
52 Week Low
$16.04
$2.15
52 Week High
$22.84
$5.45

Technical Indicators

Market Signals
Indicator
TSLX
RCKT
Relative Strength Index (RSI) 41.64 35.46
Support Level $16.66 N/A
Resistance Level $17.94 $2.73
Average True Range (ATR) 0.43 0.18
MACD -0.03 -0.01
Stochastic Oscillator 1.21 12.50

Price Performance

Historical Comparison
TSLX
RCKT

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: